Source: Crystengcomm. Unidade: IFSC
Subjects: PLANEJAMENTO DE FÁRMACOS, CRISTALIZAÇÃO, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS, Felipe T. et al. Increasing the symmetry of drug crystals: a monoclinic conformational polymorph of the platelet antiaggregating agent ticlopidine hydrochloride. Crystengcomm, v. 13, n. 19, p. 5737-5743, 2011Tradução . . Disponível em: https://doi.org/10.1039/c1ce05453h. Acesso em: 14 nov. 2024.APA
Martins, F. T., Lima, P. V., Azarias, L. C., Abreu, P. J., Neves, P. P., Legendre, A. O., et al. (2011). Increasing the symmetry of drug crystals: a monoclinic conformational polymorph of the platelet antiaggregating agent ticlopidine hydrochloride. Crystengcomm, 13( 19), 5737-5743. doi:10.1039/c1ce05453hNLM
Martins FT, Lima PV, Azarias LC, Abreu PJ, Neves PP, Legendre AO, Andrade FM, Oliveira GR, Ellena J, Doriguetto AC. Increasing the symmetry of drug crystals: a monoclinic conformational polymorph of the platelet antiaggregating agent ticlopidine hydrochloride [Internet]. Crystengcomm. 2011 ; 13( 19): 5737-5743.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1039/c1ce05453hVancouver
Martins FT, Lima PV, Azarias LC, Abreu PJ, Neves PP, Legendre AO, Andrade FM, Oliveira GR, Ellena J, Doriguetto AC. Increasing the symmetry of drug crystals: a monoclinic conformational polymorph of the platelet antiaggregating agent ticlopidine hydrochloride [Internet]. Crystengcomm. 2011 ; 13( 19): 5737-5743.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1039/c1ce05453h